Uric acid lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled cross-over preliminary study. Authors:

نویسندگان

  • Kazuhide Ogino
  • Masahiko Kato
  • Yoshiyuki Furuse
  • Yoshiharu Kinugasa
  • Katsunori Ishida
  • Shuichi Osaki
  • Osamu Igawa
  • Ichiro Hisatome
  • Chiaki Shigemasa
  • Stefan D. Anker
چکیده

Affiliations: 1 Center for Clinical Residency Program, Tottori University Hospital, Yonago Japan 2 Department of Cardiovascular Medicine, Faculty of Medicine, Tottori University, Yonago, Japan 3 Department of Cardiology, San-in Rosai Hospital, Yonago, Japan 4 Kinugawa Clinic, Osaka, Japan 5 Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medicine, Yonago, Japan 6 Division of Applied Cachexia Research, Dept. of Cardiology, Charité Campus Virchow-Klinikum, Berlin, Germany 7 Center for Stroke Research Berlin, Charite Universitätsmedizin, Berlin, Germany

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Letter by George regarding article, "Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled cross-over preliminary study".

Letter by George Regarding Article, “Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure: A Double-Blind Placebo-Controlled Cross-Over Preliminary Study” To the Editor: I read with interest the study by Ogino et al1 about the effects of the uricosuric agent benzobromarone in patients with chronic heart failure. It is a well thought out study that further adds to the c...

متن کامل

Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.

BACKGROUND Hyperuricemia is common in chronic heart failure (CHF), and it is a strong independent marker of prognosis. Upregulated xanthine oxidase (XO) activity and impaired renal excretion have been shown to account for increased serum uric acid (UA) levels in CHF. Therapeutic interventions with allopurinol to reduce UA levels by XO inhibition have been shown to be beneficial. Discussions are...

متن کامل

Azithromycin in Pityriasis Rosea: A Double-Blind, Placebo-Controlled Clinical Trial

Background: Pityriasis rosea is an inflammatory skin disorder with a known response to erythromycin. Considering similarities between erythromycin and azithromycin and lesser adverse effects of the latter, in a pilot study, we gave azithromycin to seven patients with pityriasis rosea and observed a noticeable improvement. The aim of this study was to evaluate the efficacy of azithromycin ...

متن کامل

Uric acid reduction rectifies prehypertension in obese adolescents.

Epidemiologic studies, animal models, and preliminary clinical trials in children implicate uric acid in the development of essential hypertension. Controversy remains as to whether the observations indicate a general mechanism or a surrogate phenomenon. We sought to determine whether uric acid is a causative mediator of increased blood pressure (BP) and impaired vascular compliance. We report ...

متن کامل

A double-blind, placebo-controlled evaluation of Vitex agnus castus premenstrual syndrom

The objective of this study was to assess the effect of Vitex agnus castus (VACS) extract in the alleviation of the symptoms of premenstrual syndrome. The study was designed as a double-blind, placebo controlled trial in two parallels groups (15 patients each). Treatment phase lasted 3 consequent menstrual cycles (2*30 drops/day=1.8 ml of VACS) or placebo. For assessment of the efficacy visual ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009